Suppr超能文献

开发无定形固体分散体的制造策略:综述。

Manufacturing strategies to develop amorphous solid dispersions: An overview.

作者信息

Mendonsa Nicole, Almutairy Bjad, Kallakunta Venkata Raman, Sarabu Sandeep, Thipsay Priyanka, Bandari Suresh, Repka Michael A

机构信息

Department of Pharmaceutics and Drug Delivery, The University of Mississippi, Oxford, MS, 38677, United States.

Pii Center for Pharmaceutical Innovation & Instruction, The University of Mississippi, Oxford, MS, 38677, United States.

出版信息

J Drug Deliv Sci Technol. 2020 Feb;55. doi: 10.1016/j.jddst.2019.101459. Epub 2019 Dec 11.

Abstract

Since the past several decades, poor water solubility of existing and new drugs in the pipeline have remained a challenging issue for the pharmaceutical industry. Literature describes several approaches to improve the overall solubility, dissolution rate, and bioavailability of drugs with poor water solubility. Moreover, the development of amorphous solid dispersion (SD) using suitable polymers and methods have gained considerable importance in the recent past. In the present review, we attempt to discuss the important and industrially scalable thermal strategies for the development of amorphous SD. These include both solvent (spray drying and fluid bed processing) and fusion (hot melt extrusion and KinetiSol®) based techniques. The current review also provides insights into the thermodynamic properties of drugs, their polymer miscibility and solubility, and their molecular dynamics to develop stable and more efficient amorphous SD.

摘要

在过去几十年中,现有药物以及研发管线中的新药水溶性差一直是制药行业面临的一个具有挑战性的问题。文献中描述了几种提高水溶性差的药物的整体溶解度、溶出速率和生物利用度的方法。此外,使用合适的聚合物和方法开发无定形固体分散体(SD)在最近变得相当重要。在本综述中,我们试图讨论用于开发无定形SD的重要且可工业规模放大的热策略。这些策略包括基于溶剂的技术(喷雾干燥和流化床工艺)以及基于熔融的技术(热熔挤出和KinetiSol®)。本综述还深入探讨了药物的热力学性质、它们与聚合物的混溶性和溶解性,以及它们的分子动力学,以开发稳定且更高效的无定形SD。

相似文献

1
Manufacturing strategies to develop amorphous solid dispersions: An overview.
J Drug Deliv Sci Technol. 2020 Feb;55. doi: 10.1016/j.jddst.2019.101459. Epub 2019 Dec 11.
3
Innovations in Thermal Processing: Hot-Melt Extrusion and KinetiSol® Dispersing.
AAPS PharmSciTech. 2020 Nov 8;21(8):312. doi: 10.1208/s12249-020-01854-2.
4
Homogeneity of amorphous solid dispersions - an example with KinetiSol.
Drug Dev Ind Pharm. 2019 May;45(5):724-735. doi: 10.1080/03639045.2019.1569037. Epub 2019 Jan 25.
5
Hot melt extrusion versus spray drying: hot melt extrusion degrades albendazole.
Drug Dev Ind Pharm. 2017 May;43(5):797-811. doi: 10.1080/03639045.2016.1220577. Epub 2016 Oct 20.
6
Recent strategies in spray drying for the enhanced bioavailability of poorly water-soluble drugs.
J Control Release. 2018 Jan 10;269:110-127. doi: 10.1016/j.jconrel.2017.11.005. Epub 2017 Nov 5.
8
Expanding the Application and Formulation Space of Amorphous Solid Dispersions with KinetiSol®: a Review.
AAPS PharmSciTech. 2018 Jul;19(5):1933-1956. doi: 10.1208/s12249-018-1007-2. Epub 2018 May 30.

引用本文的文献

2
Polymers Enhance Chlortetracycline Hydrochloride Solubility.
Int J Mol Sci. 2024 Oct 1;25(19):10591. doi: 10.3390/ijms251910591.
4
6
Dissolution-permeation of hot-melt extruded amorphous solid dispersion comprising an experimental grade of HPMCAS.
ADMET DMPK. 2023 Jul 22;11(3):373-385. doi: 10.5599/admet.1586. eCollection 2023.
7
Amorphous Solid Dispersion as Drug Delivery Vehicles in Cancer.
Polymers (Basel). 2023 Aug 11;15(16):3380. doi: 10.3390/polym15163380.
9
Release Enhancement by Plasticizer Inclusion for Amorphous Solid Dispersions Containing High T Drugs.
Pharm Res. 2023 Mar;40(3):777-790. doi: 10.1007/s11095-023-03483-3. Epub 2023 Mar 1.
10
The Role of Microsphere Structures in Bottom-Up Bone Tissue Engineering.
Pharmaceutics. 2023 Jan 18;15(2):321. doi: 10.3390/pharmaceutics15020321.

本文引用的文献

1
Processability of AquaSolve™ LG polymer by hot-melt extrusion: Effects of pressurized CO on physicomechanical properties and API stability.
J Drug Deliv Sci Technol. 2019 Aug;52:165-176. doi: 10.1016/j.jddst.2019.04.029. Epub 2019 Apr 18.
2
A quality by design approach to develop topical creams via hot-melt extrusion technology.
Eur J Pharm Sci. 2019 Aug 1;136:104948. doi: 10.1016/j.ejps.2019.06.002. Epub 2019 Jun 4.
4
Solubility and bioavailability enhancement study of lopinavir solid dispersion matrixed with a polymeric surfactant - Soluplus.
Eur J Pharm Sci. 2019 Jun 15;134:233-245. doi: 10.1016/j.ejps.2019.04.022. Epub 2019 Apr 24.
5
An update on the contribution of hot-melt extrusion technology to novel drug delivery in the twenty-first century: part I.
Expert Opin Drug Deliv. 2019 May;16(5):539-550. doi: 10.1080/17425247.2019.1609448. Epub 2019 May 3.
6
Inhalable co-amorphous budesonide-arginine dry powders prepared by spray drying.
Int J Pharm. 2019 Jun 30;565:1-8. doi: 10.1016/j.ijpharm.2019.04.036. Epub 2019 Apr 15.
7
Evaluation of the suitability of a fluidized bed process for the coating of drug-eluting stents.
Eur J Pharm Biopharm. 2019 Jun;139:85-92. doi: 10.1016/j.ejpb.2019.03.013. Epub 2019 Mar 13.
9
Modeling, design and manufacture of innovative floating gastroretentive drug delivery systems based on hot-melt extruded tubes.
Eur J Pharm Biopharm. 2019 Apr;137:196-208. doi: 10.1016/j.ejpb.2019.02.022. Epub 2019 Feb 28.
10
Molecular simulation as a computational pharmaceutics tool to predict drug solubility, solubilization processes and partitioning.
Eur J Pharm Biopharm. 2019 Apr;137:46-55. doi: 10.1016/j.ejpb.2019.02.007. Epub 2019 Feb 14.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验